Oral transmucosal fentanyl citrate in the management of dyspnea crisis in cancer patients

被引：21
|
作者：
Benitez-Rosario, MA [1 ]
Martin, AS
Feria, M
机构：
[1] Hosp La Candelaria, Palliat Care Unit, Tenerife, Spain
[2] Hosp La Candelaria, Res Unit, Tenerife, Spain
[3] Univ La Laguna, Dept Pharmacol, Tenerife, Spain
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2005年 / 30卷 / 05期
关键词：
D O I：
10.1016/j.jpainsymman.2005.10.002
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：395 / 397
页数：3
相关论文
共 50 条
  • [31] Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate
    Kharasch, ED
    Hoffer, C
    Whittington, D
    ANESTHESIOLOGY, 2004, 101 (03) : 738 - 743
  • [32] ORAL TRANSMUCOSAL FENTANYL CITRATE FOR ANALGESIA AND SEDATION IN THE EMERGENCY DEPARTMENT
    LIND, GH
    MARCUS, MA
    MEARS, SL
    ASHBURN, MA
    PETERSON, BJ
    BERNHISEL, KT
    STANLEY, TH
    ANNALS OF EMERGENCY MEDICINE, 1991, 20 (10) : 1117 - 1120
  • [33] ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF POSTOPERATIVE PAIN
    ASHBURN, MA
    LIND, GH
    GILLIE, MH
    DEBOER, AJF
    PACE, NL
    STANLEY, TH
    ANESTHESIA AND ANALGESIA, 1993, 76 (02): : 377 - 381
  • [34] ORAL TRANSMUCOSAL FENTANYL CITRATE (LOLLIPOP) PREMEDICATION IN HUMAN VOLUNTEERS
    STANLEY, TH
    HAGUE, B
    MOCK, DL
    STREISAND, JB
    BUBBERS, S
    DZELZKALNS, RR
    BAILEY, PL
    PACE, NL
    EAST, KA
    ASHBURN, MA
    ANESTHESIA AND ANALGESIA, 1989, 69 (01): : 21 - 27
  • [35] Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain
    Payne, R
    Coluzzi, P
    Hart, L
    Simmonds, M
    Lyss, A
    Rauck, R
    Berris, R
    Busch, MA
    Nordbrook, E
    Loseth, DB
    Portenoy, RK
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (01) : 575 - 583
  • [36] THE USE OF ORAL TRANSMUCOSAL FENTANYL CITRATE FOR PAINFUL PROCEDURES IN CHILDREN
    SCHECHTER, NL
    WEISMAN, SJ
    ROSENBLUM, M
    BERNSTEIN, B
    CONARD, PL
    PEDIATRICS, 1995, 95 (03) : 335 - 339
  • [37] Oral transmucosal fentanyl citrate: Overview of pharmacological and clinical characteristics
    Mystakidou, Kyriaki
    Katsouda, Emmanuela
    Parpa, Efi
    Vlahos, Lambros
    Tsiatas, Marinos L.
    DRUG DELIVERY, 2006, 13 (04) : 269 - 276
  • [38] ORAL TRANSMUCOSAL FENTANYL CITRATE FOR THE TREATMENT OF BREAKTHROUGH CANCER PAIN - A CASE-REPORT
    ASHBURN, MA
    FINE, PG
    STANLEY, TH
    ANESTHESIOLOGY, 1989, 71 (04) : 615 - 617
  • [39] ORAL TRANSMUCOSAL FENTANYL CITRATE FOR PREANESTHETIC MEDICATION OF PEDIATRIC CARDIAC-SURGERY PATIENTS
    FRIESEN, RH
    CARPENTER, E
    MADIGAN, CK
    LOCKHART, CH
    PAEDIATRIC ANAESTHESIA, 1995, 5 (01): : 29 - 33
  • [40] Reducing postoperative agitation in pediatric patients: Oral transmucosal fentanyl citrate with without ondansetron
    Binstock, W
    Toledano, A
    Lichtor, J
    Dorfman, R
    Bachman, C
    Coalson, D
    Conran, A
    Kahana, M
    Kulkarni, V
    McDade, W
    ANESTHESIA AND ANALGESIA, 1999, 88 (02):
12345